PRP guidelines · International

Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial

Ying-Chun Wang, Chia-Ling Lee, Yu-Jen Chen, Yin-Chun Tien, Sung-Yen Lin, Chung-Hwan Chen, Paul Pei-Hsi Chou, Hsuan-Ti Huang

Medicina · 2022

In brief

A double-blind randomised controlled trial compared a single platelet-rich plasma (PRP) injection with a single injection of a newer cross-linked hyaluronic acid product for early knee osteoarthritis. Both groups improved over several months of follow-up, and the authors found no meaningful difference between the two treatments.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Comparing the Efficacy of Intra-Articular Single Platelet-Rich Plasma(PRP) versus Novel Crosslinked Hyaluronic Acid for Early-Stage Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial Authors: Ying-Chun Wang, Chia-Ling Lee, Yu-Jen Chen, Yin-Chun Tien, Sung-Yen Lin, Chung-Hwan Chen, Paul Pei-Hsi Chou, Hsuan-Ti Huang Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9415551/ Year of Publication: 2022

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.